Proteomic profiles for Alzheimers disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimers Biomarker Consortium–Down Syndrome (ABC–DS) study

摘要

Previously generated serum and plasma proteomic profiles were examined among adults with Down syndrome (DS) to determine whether these profiles could discriminate those with mild cognitive impairment (MCI‐DS) and Alzheimer's disease (DS‐AD) from those cognitively stable (CS).